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Abstract
Background: Whilst nutrition is vital to survival in health, the precise role of nutrition during critical illness is
controversial. More specifically, the exact amount of energy that is required during critical illness to optimally
influence clinical outcomes remains unknown. The aim of this systematic literature review and meta-analysis is
to evaluate the clinical effects of optimising nutrition to critically ill adult patients, such that the entire predicted
amount of energy that the patient requires is delivered, on mortality and other important outcomes.
Methods: A systematic literature review and meta-analysis will be conducted by searching for studies indexed in
Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica Database (EMBASE), Cumulative
Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Library. Searches will be restricted to
English. Studies will be considered for inclusion if they are a parallel randomised controlled trial investigating a
nutrition intervention in an adult critical care population, where one arm delivers ‘full predicted energy from
nutrition’ (defined as provision of ≥80 % of the predicted energy required) and the other arm delivers energy less
than 80 % of the predicted requirement. Two authors will independently perform title screening, full-text screening,
data extraction and quality assessment for this review. The quality of individual studies will be assessed using the
‘Risk of Bias’ tool, and to assess the overall body of evidence, a ‘Summary of Findings’ table and the Grades of
Recommendation, Assessment, Development and Evaluation system will be used, all recommended by the
Cochrane Library. Pending the study heterogeneity that is determined, a fixed-effect meta-analysis with pre-defined
subgroup analyses will be performed.
Discussion: Currently, it is controversial whether optimal energy delivery is beneficial for outcomes in critically ill
patients. This systematic review and meta-analysis will evaluate whether delivering optimal energy to critically ill
adult patients improves outcomes when compared to delivery of lesser amounts.
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Background
Nutrition is vital to survival in health. In critical illness,
however, the role of nutrition is less defined. More specif-
ically, the exact amount of energy that is required during
critical illness to optimally influence clinical outcomes
remains unknown. Prolonged provision of nutrition below
a patient’s individual nutrition requirements (including
under provision of energy, specifically) can result in mal-
nutrition. Whist the prevalence of malnutrition in critic-
ally ill patients is generally poorly documented, poorly
defined, and varies depending on the criteria used, reports
indicate that worldwide prevalence in hospitalised patients
is between 20 and 50 % internationally [1]. Malnutrition is
thus likely to be commonplace in critically ill patients. In
the acute hospitalised population, malnutrition has been
associated with many undesirable clinical consequences
such as reduced immune function, increased length of
hospital stay, impaired wound healing, muscle wasting
and ultimately increased health care costs [1]. Conversely,
it is known that excessive nutrition can lead to over
provision of energy and result in adverse patient effects in-
cluding increased metabolic stress, hyperglycaemia and
deranged liver function [2].
Despite the known consequences of significant under-
or overfeeding in critically ill patients, there is consider-
able uncertainty regarding the ideal amount of energy to
provide to optimise outcomes. One of the most significant
issues in studies of critical illness nutrition is that delivery
of the full (or even near-full) predicted energy amounts
(where the full amount of energy a patient is predicted to
require is administered) has been uncommon. This often
leads to all patient groups in nutrition studies receiving
less than their full predicted energy requirements [3–7].
This occurs in clinical practice too, with a large inter-
national multicentre observational study including 158
intensive care units (ICUs) and 2946 patients indicating
that only 45 % of predicted energy was provided by stand-
ard enteral nutrition (EN) alone, probably due to delays in
commencement, intestinal dysfunction, and withholding
of EN for medical procedures [8–10]. Several small studies
have suggested improved clinical outcomes when energy
delivery approximates full predicted energy requirements
from nutrition; however, this evidence has not been trans-
lated into clinical practice [11–13].
Given the lack of clear evidence to make recom-
mendations regarding the optimum amount of energy
to provide to critically ill patients, we sought to con-
duct a systematic review to aggregate and summarise
the evidence from the trials in this field to inform fu-
ture research and clinical practice.
Objectives
The aim of this systematic literature review and meta-
analysis is to assess the effect of delivery of full predicted
energy from nutrition on mortality and other important
clinical outcomes in critically ill adults. ‘Full predicted
energy from nutrition’ is defined as provision of ≥80 %
of the predicted energy determined by any method, and
the comparator will be the delivery of energy less than
80 % of the predicted requirement determined by any
method.
The clinical question posed in this review is ‘Does
the delivery of full predicted energy from nutrition
influence mortality or other important clinical out-
comes in critically ill adults compared to the delivery
of less than full predicted energy from nutrition?’
Methods/design
A rigorous systematic review and meta-analysis of ran-
domised controlled trials (RCTs) will be conducted
using the methodology detailed in the Cochrane Hand-
book for Systematic Reviews of Interventions [14] and
the Centre for Research and Dissemination (CRD)’s
Guidance for Undertaking Reviews in Health Care [15].
Population
We will include studies in critically ill adult patients
(≥16 years) irrespective of admission diagnosis that receive
enteral and/or parenteral nutrition (PN).
Study participants will be defined as ‘critically ill’ if they
meet one of the following criteria (adapted from Simpson
and Doig 2005 [16]):
1. The patients were recruited in an ICU.
2. The inclusion criteria specified in the study deemed
that the patients would be required to be cared for
in an ICU, i.e. invasive organ support.
3. The patients had an average ICU length of stay of
greater than or equal to 2 days.
Interventions and comparators
The intervention group (delivery of full predicted energy
from nutrition) will comprise study arms which report
that patients received a mean energy delivery of ≥80 %
of estimated or measured energy requirements. Energy
delivery must be provided by EN and/or PN but may
also include some non-nutritional calorie sources such
as propofol and dextrose. The alternate arm will be the
control (comparator) group (mean energy delivery
<80 % of full predicted energy requirements).
The metric of ≥80 % of estimated or measured energy
requirements was chosen by the authors as it is above
the international mean for energy delivery, it approxi-
mates energy requirements and observational evidence
is emerging that receipt of ≥80 % of estimated energy
requirements may improve clinical outcomes in certain
patient groups [8, 17].




2. Hospital length of stay
3. Infectious complications
Infectious complications will be defined as any confirmed
infectious event after randomisation, reported as the total
number of events for each arm of the RCT, if an objective
measure is described (i.e. positive blood culture).
Secondary
1. ICU and 90-day mortality
2. Duration of mechanical ventilation in survivors and
non-survivors, measured in days
3. ICU and hospital length of stay in survivors and
non-survivors, measured in days
Inclusion criteria
Trials will be screened based on the following inclusion
criteria:
1. Parallel group randomised controlled trials.
2. Mortality, hospital length of stay and/or infectious
complications have been reported.
3. Patients were randomised into the study within 72 h
of admission and nutrition therapy was commenced
to both arms within 72 h of admission or appears to
have been if it is not precisely reported.
4. Energy delivery from EN, PN or any combination is
reported as a proportion of estimated requirements
(by any method) or the required data to calculate
this is provided.
5. One arm of the trial reports mean energy delivery of
≥80–120 % of the estimated or measured energy
requirements, and the other reports mean energy
delivery of <80 % of the estimated or measured
energy requirements.
6. Conducted in adult (≥16 years) critically ill patients.
7. Both study arms received carbohydrate, lipid and
protein as part of nutrition therapy.
8. The primary intervention in the research study was
delivered as a component of nutrition therapy.
Abstracts alone, where the subsequent primary publi-
cation cannot be located, will be excluded.
We will not include cluster-randomised trials, non-
randomised or quasi-randomised trials. We will also ex-
clude cross-over trials because this methodology will not
allow us to investigate the outcomes we have chosen.
Search strategy
The current issues of the Cochrane Central Register of
Controlled Trials (CENTRAL), Medical Literature Analysis
and Retrieval System Online (MEDLINE) (Ovid SP, from
1948 to date), Excerpta Medica Database (EMBASE) (Ovid
SP, from 1948 to date) and the Cumulative Index to Nurs-
ing and Allied Health Literature (CINAHL) (EBSCOhost,
from 1948 to date) will be searched. Sensitivity-maximising
strategies will be applied for each database as described in
the Cochrane Handbook for Systematic Reviews of Inter-
ventions [14], and advice from a senior librarian with exten-
sive knowledge in the area of medical systematic review will
be sought. Publication restrictions for English language and
studies containing adults and humans will be used pending
the accuracy of the indexing for each search engine and at
the advice of the senior librarian. Appendix demonstrates
the MEDLINE search strategy which will be adopted for
other search engines. Once included studies are identified,
the reference lists, other systematic reviews on similar
topics and clinical practice guidelines will be hand-searched
to identify any other potential articles.
Study selection and management of review processes
The EndNote reference manager software program (version
X7.3, New York City: Thomas Reuters, 2011) and online
systematic review management program, Covidence 2013
(www.covidence.org) will be used to coordinate the screen-
ing and data collection process. Covidence allows multiple
authors to independently conduct the processes associated
with a systematic review and then resolve any conflicts
whilst tracking processes.
At each stage of study screening, selection for inclusion
and exclusion criteria and data extraction processes, two
authors will independently pilot suggested processes on 10
papers and then discuss to assess agreement, refine pro-
cesses and ensure there is consistency in methodology.
Once a final methodology has been agreed upon, it will be
imputed into Covidence and used for the full set of articles
as a final version at each stage.
Study selection
Results of the searches described above will be merged in
the reference manager software. Selection of relevant arti-
cles will be conducted in stages.
Stage 1: Remove duplicates
Using the reference manager software, one author will
remove obvious duplicate articles from the initial search.
Stage 2: Remove irrelevant articles
Using the reference manager software one author will
remove obviously irrelevant articles and those which
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are not RCTs (editorials, letters, abstracts, reviews,
meta-analysis). This will be checked by the second
author and over inclusion for screening will be
preferred to exclusion at this stage.
The final list after removal of duplicates and irrelevant
articles will be uploaded into Covidence systematic
review software for screening by two authors
independently.
Stage 3: Determine a final list of potentially relevant
articles
Two authors will then independently screen titles and
abstracts using the Covidence software to determine a
final list of potentially relevant studies for full-text
review. After this screening process, the results will be
compared and any conflicts resolved by discussion.
Where eligibility cannot be determined using the
abstract alone, the article will remain in consideration
and the full text will be obtained. In the case of inability
to reach consensus, a third review author will be
consulted. Once a list of potentially relevant articles
has been produced, the full text will be retrieved.
Stage 4: Retrieve full-text reports for compliance of
studies and determine eligibility criteria
The same two authors will independently assess the
full-text articles using a hierarchy of inclusion criteria
previously outlined. The reasons for exclusion and any
conflicts will be independently noted.
Conflicts will be resolved by discussion, with the two
authors using the hierarchy of inclusion criteria to re-
assess the articles together in an attempt to obtain a
consensus for inclusion or exclusion. In cases of inability
to reach a consensus, a third review author will be asked
to independently assess the article. A final list will be
compiled of all eligible studies along with a list of ex-
cluded studies based on the review of the authors. The
reference lists of the included studies and systematic re-
views of similar topics (with and without meta-analysis)
will also be checked to ensure there are no missing rele-
vant articles. The final list of included and excluded
studies will be discussed with the whole authorship
group and any articles that may have been excluded but
would have been expected to be included prior to assess-
ment will be presented to ensure we have consensus and
a ‘characteristics of excluded studies’ table will be devel-
oped. Any eligible studies will also be reviewed and com-
pared at this stage to ensure there are no duplicate
reports of studies.
Data extraction
Study data extraction points will be developed based on
the Cochrane Collaboration Study Selection and Data
Extraction form [14]. These study characteristics will be
pre-specified prior to data extraction and relate to patient
and setting characteristics, study methodology, detailed
data on nutrition therapy (including mode delivered, en-
ergy requirements (estimated or measured), energy deliv-
ered and duration of nutrition therapy) and detailed data
on outcome variables such as how they were defined, how
they were reported, the sample sizes in each group, miss-
ing data and any other relevant comments on each paper.
Assessment of bias in included studies
Two review authors will independently assess the risk of
bias in included articles using the Cochrane risk of bias
tool, with a particular focus on sequence generation,
allocation concealment, blinding, incomplete or selective
reporting of outcome data and other sources of bias as
recommended in the Cochrane Handbook for assessment
of parallel trials [14]. To ensure consistency in assessment
between authors, we will use the exact instructions pro-
vided by Cochrane for each domain, as set out in the
Cochrane Handbook [14]. Where there is disagreement
between author assessments, a conservative approach will
be favoured, where article quality will be downgraded in
the first instance. If consensus cannot be reached, a third
author will be required to assess the article(s).
Assessment of reporting biases
If 10 or more studies are identified, funnel plot, as rec-
ommended by Egger [18], will be created using the stat-
istical software of The Cochrane Collaboration, Review
Manager (RevMan) 5.3 [19]. We will conduct sensitivity
analyses to explore the robustness of the meta-analysis
in terms of conclusions related to the causes of funnel
plot asymmetry.
Data synthesis
Only available data will be synthesised; no missing date
will be imputed. The included data will be quantitatively
reviewed and combined by energy delivery for each speci-
fied primary and secondary outcome using RevMan 5.3
[19]. We will synthesise these data only in the absence of
important clinical or statistical heterogeneity (see defin-
ition of important heterogeneity under ‘Assessment of
statistical heterogeneity’ below).
Unit of analysis issues
We will include in our review only RCTs with a parallel-
group design. The issue of repeated measures is not rele-
vant for the outcomes under investigation.
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Where different scales are used to measure the same
outcome, we will present the treatment effect as the
standardised mean difference (SMD) with 95 % confi-
dence intervals (CIs). Measurements in different units
will not be combined.
Assessment of statistical heterogeneity
We will consider the χ2 statistic to test statistical hetero-
geneity between studies and will consider a P value ≤0.10
as indicating significant statistical heterogeneity; we will
use the I2 statistic to assess the magnitude of heterogen-
eity [14]. We will consider I2 > 50 % to indicate problem-
atic heterogeneity between studies and will carefully
consider the value of any pooled analysis. If I2 is greater
than 50 %, we will use a random-effects model analysis to
determine the best estimate of the intervention effect;
otherwise, a fixed-effect model of analysis will be used. If
the two do not coincide, we will not consider the random-
effects estimate as the actual intervention effect in the
population under study. We will construct forest plots to
summarise findings from the included studies.
Statistical analysis and measures of treatment effect
The analysis will be undertaken using RevMan 5.3 soft-
ware [19].
One of the primary outcomes (mortality) and one of the
secondary outcomes (infectious outcomes) is binomial,
whilst all other outcomes are continuous.
For binomial outcomes, we will present the treatment
effect as an odds ratio (OR) with 95 % CIs.
For continuous outcomes, we will present the treatment
effect as a mean difference (MD) or SMD with 95 % CIs.
If variables are found to be non-normally distributed,
appropriate statistical methods will be utilised for analysis
where possible.
In addition to analysing the primary outcome variable
(mortality) as a binomial variable, should sufficient data
exist, we will also conduct time to event analysis for
survival with results reported as hazard ratio (HR) with
95 % CIs in accordance with Tierney at al. and as speci-
fied in the Cochrane Handbook [14, 20]. Analysis using
this data will be conducted using the generic inverse-
variance method and the fixed and random effect ana-
lyses compared.
Subgroup analyses have been defined a priori. If obvious
unexplained heterogeneity is observed (I2 > 50 %) between
studies, we will consider other subgroup analysis and re-
port these separately. Further, where studies of high qual-
ity and at low risk of bias exist, we will consider doing a
separate analysis with these studies alone to further inves-
tigate any clinical effect. All analyses will be presented in
the final paper. Where subgroup analyses are performed,
the method described by Deeks and recommended by
Cochrane will be used [14, 21].
Subgroup analyses
A priori, and pending study numbers, we would like to
conduct subgroup analysis of:
 Studies using only EN in the intervention group
 Studies using only PN in the intervention group
 Studies using EN and PN in the intervention group
 Trials investigating immunonutrition as the primary
intervention
 Studies assessed as high quality and low risk of bias
These subgroups have been chosen as it is plausible
that the mode of nutrition therapy may affect the speci-
fied outcomes differently. Immunonutrition has been
pre-specified as the literature in this area is conflicting
(and may include harm in the critically ill [22]) and so
separate analysis is warranted.
Summary of findings and quality of the body of evidence
We will present study findings in a standard ‘Summary
of Findings’ (SOF) table, which will include the magni-
tude of effect, the numbers of participants and studies
addressing each outcome and a grade for the overall
quality of the body of evidence for each outcome. Space
will be provided for comments.
We will use the principles of the Grades of Recom-
mendation, Assessment, Development and Evaluation
system [23] to assess the quality of the body of evidence
associated with specific outcomes.
Publication
The results of the meta-analysis will be published in a peer
reviewed journal with all contributors listed as authors.
Discussion
Inform future studies
This systematic review and meta-analysis will inform the
design of future nutrition studies investigating the rela-
tionship of energy dose in critical illness. We will also
identify the gaps in the literature and trial design in rela-
tion to energy dose in nutrition research, which may assist
in improving methodological quality of future studies.
Nutrition is a universally provided standard of care to the
critically ill and is inexpensive compared to other therap-
ies, but the risks and benefits to patient outcomes are re-
markably poorly understood.
Expected benefits of this review
This will be the first published systematic review and
meta-analysis to our knowledge that will investigate the
effect of delivering full predicted energy from nutrition
Ridley et al. Systematic Reviews  (2015) 4:179 Page 5 of 7
on clinical outcomes in critically ill adults, compared to
delivering less than full predicted energy requirements.
The literature available on this topic is conflicting and
confusing for clinicians and could potentially lead to
misleading conclusions being made regarding the role of
nutrition in critical illness. This systematic review and
meta-analysis will benefit clinicians by providing a sum-
mary of the available literature and provide further
guidance.
Appendix
Table 1 Sample search strategy for MEDLINE (other searches will be based on this)
Number Searches
1 (((intensive or critica*) adj3 (care or unit* or illness*)) or ICU or (critical* adj ill) or (mechanical* adj4 ventilat*)).tw.
2 (artificial* adj2 (respirat* or ventilat*)).tw.
3 exp critical illness/ or exp critical care/ or exp intensive care/ or exp respiration, artificial/ or exp ventilation, mechanical/ or exp critical care
nursing/ or exp intensive care units/
4 exp Multiple Organ Failure/ or exp Systemic Inflammatory Response Syndrome/
5 (multiple organ dysfunction* or multiple organ failure* or multi-organ failure* or Systemic Inflammatory Response or septic shock or sepsis
syndrome*).tw.
6 Respiratory Distress Syndrome, Adult/
7 Respiratory Distress Syndrome*.tw.
8 1 or 2 or 3 or 4 or 5 or 6 or 7
9 ((calorie* or energy) and (nutrient* or nutrition* or diet*)).tw.
10 (calori* or energy or underfe* or overfe* or hypercaloric or undernutrition or underprescription).tw.
11 exp intubation, gastrointestinal/
12 exp energy intake/ or exp caloric restriction/ or exp nutrition assessment/ or exp nutritional requirements/ or exp nutritional support/ or
exp nutritional status/ or exp parenteral nutrition/ or energy metabolism/ or basal metabolism/ or nutrition therapy/ or exp enteral
nutrition/
13 ((parenteral* or intravenous*) adj2 (feed or feeding or feeds or fed or nutrition)).tw.
14 ((enteral* or enteric or nasogastric) adj2 (feed or feeding or feeds or fed or nutrition)).tw.
15 (nutrition assessment* or nutrition* requirement* or nutrition* support* or nutrition* status or basal metabolism or nutrition* therap*).tw.
16 exp dietary supplements/
17 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18 8 and 17
19 (randomized controlled trial or controlled clinical trial).pt. or (random* or trial or placebo).tw. or clinical trial*.pt.
20 18 and 19
21 exp animals/ not humans.sh.
22 (child* or infan* or pediatr* or paediatr* or neonat* or preterm or newborn* or NICU).mp.
23 20 not (21 or 22)
24 limit 23 to english language
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